Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
IL5 mAb | Monospecific antibody | Immunological disease | Asthma | Phase II | Global (except China) |
製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
---|---|---|---|---|---|
EP-128 | Human | IL-5[Biotinylated]:IL-5Rα Inhibitor Screening ELISA Kit | |||
IL5-C52H3 | Cynomolgus | Cynomolgus IL-5 Protein, His Tag |
|
||
IL5-M52H3 | Mouse | Mouse IL-5 Protein, His Tag (MALS verified) |
|
||
IL5-R52H4 | Rabbit | Rabbit IL-5 Protein, His Tag |
|
||
IL5-H82Q5 | Human | Biotinylated Human IL-5 Protein, His,Avitag™ |
|
||
IL5-H52H3 | Human | Human IL-5 Protein, His Tag, premium grade |
|
Loaded Human IL-5, His Tag, premium grade (Cat. No. IL5-H52H3) on NTA Biosensor, can bind Human IL-5 R alpha, Fc Tag with an affinity constant of 4.63 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Reslizumab | TRFK-5; CDP-835; SCH-5570; CEP-38072; CTx-55700; SCH-55700 | Approved | Teva Pharmaceutical Industries Ltd | Cinqair, Cinquil, Cinqaero | EU | Asthma | Teva Bv | 2016-03-23 | Loiasis; Hypereosinophilic Syndrome; Pulmonary Eosinophilia; Eosinophilic Esophagitis; Asthma; Bronchitis | Details |
Mepolizumab | SB-240563; 240563 | Approved | Glaxosmithkline Plc | Bosatria, Nucala, 美泊利珠单抗 | EU | Eosinophilic Granuloma; Nasal Polyps; Hypereosinophilic Syndrome; Sinusitis | Glaxosmithkline Trading Services Ltd | 2015-11-04 | Hypereosinophilic Syndrome; Granulomatosis with Polyangiitis; Churg-Strauss Syndrome; Virus Diseases; Nasal Polyps; Chronic Urticaria; Eosinophilia; Eosinophilic Esophagitis; Asthma; Eosinophilic Granuloma; Bronchitis; Sinusitis; Pulmonary Disease, Chronic Obstructive; Fasciitis; Dermatitis, Atopic; Angioedema | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
long-acting anti-IL-5 mAb (GSK) | Phase 1 Clinical | Glaxosmithkline Plc | Asthma | Details | |
Mepolizumab biosimilar (CTTQ Pharma) | Phase 1 Clinical | Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group | Hypereosinophilic Syndrome; Vasculitis; Nasal Polyps; Asthma; Eosinophilic Granuloma; Sinusitis | Details | |
Mepolizumab biosimilar(Bio Thera Solutions) | Phase 1 Clinical | Bio-Thera Solutions Ltd | Autoimmune Diseases; Nasal Polyps; Sinusitis | Details | |
SHR-1703 | SHR-1703 | Phase 2 Clinical | Suzhou Suncadia Biopharmaceuticals Co Ltd, Jiangsu Hengrui Medicine Co Ltd, Shanghai Hengrui Pharmaceutical Co Ltd | Asthma | Details |
Recombinant anti-IL-5 humanized monoclonal antibody (Shanghai CP Guojian) | 610 | Phase 2 Clinical | Shanghai Cp Guojian Pharmaceutical Co Ltd | Autoimmune Diseases; Asthma | Details |
Depemokimab | GSK-294; GSK3511294; GSK294; GSK-3511294 | Phase 3 Clinical | Glaxosmithkline Plc | Hypereosinophilic Syndrome; Churg-Strauss Syndrome; Nasal Polyps; Vasculitis; Asthma; Eosinophilic Granuloma; Sinusitis | Details |
This web search service is supported by Google Inc.